Class Action Lawsuit Against Accelerate Diagnostics, Inc. on Behalf of Accelerate Diagnostics, Inc. Investors
Accelerate Diagnostics, Inc. Lawsuit Details
On March 19, 2015, a securities class action lawsuit was filed on behalf of purchasers of Accelerate Diagnostics, Inc. (NASDAQ: AXDX) common stock. Specifically, the complaint alleges violations of the federal securities laws, including alleging the issuance of material false and misleading representations to the market which had the effect of artificially inflating the market price of the Company stock beginning March 7, 2014 through February 17, 2015. The lawsuit alleges that the Company misrepresented the capability and description of its main product, the ID/AST system (formally known as the BACcel system).
Legal Help for Accelerate Diagnostics, Inc. Investors
If you purchased or otherwise acquired shares of Accelerate Diagnostics, Inc., you may have legal claims under federal securities laws. You may contact Gilman Law LLP to discuss your rights to recovery of your losses or to obtain additional information.
About Our Investment Fraud Attorneys
The Securities Fraud Attorneys at Gilman Law have over 35 years of experience in securities litigation. Our Investment Fraud Attorneys focus on cases involving securities litigation, securities fraud, mergers and acquisitions, breach of fiduciary duty and other shareholder disputes.
For a free evaluation of your case or to obtain additional information, please complete the Investor Certification or CALL TOLL FREE (888) 252-0048.